• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖:全身性炎症状态下局部肾细胞癌的独立保护因素。

Obesity: An independent protective factor for localized renal cell carcinoma in a systemic inflammation state.

机构信息

Department of Urology, Peking University First Hospital and Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.

Department of Anesthesiology, Peking University First Hospital, Peking University, Beijing, China.

出版信息

Int Braz J Urol. 2020 Jul-Aug;46(4):585-598. doi: 10.1590/S1677-5538.IBJU.2019.0228. Epub 2020 Mar 15.

DOI:10.1590/S1677-5538.IBJU.2019.0228
PMID:32213207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7239303/
Abstract

OBJECTIVES

To explore the prognostic value of obesity (measured by BMI) on RCC in a systemic inflammation state.

PATIENTS AND METHODS

Clinicopathological and hematological data of 540 surgically treated Chinese localized RCC patients between 2005 and 2010 were retrospectively collected. Found by receiver operating characteristic (ROC) curve for cancer-specific survival (CSS), the optimal cutoff values of neutrophil-lymphocyte ratio (NLR, an indicator of systemic inflammation state) and BMI were 2.12 and 23.32, respectively. Survival curves were drawn using Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to evaluate the prognostic value of BMI in localized RCC patients with different NLR.

RESULTS

Overall, 36 patients died with a median follow-up of 70 months. Median overall survival (OS) was 66 months and the 5-year OS rate was 92.7%. In the multivariate analysis of total patients, higher BMI was an independent protective factor for CSS in total patients (p=0.048). While in systemic inflammation subgroup (high NLR subgroup) patients, higher BMI (obesity) turned out to be an independent protective factor for both CSS (p=0.025) and RFS (p=0.048).

CONCLUSION

In localized RCC patients, obesity was an independent protective factor for CSS and RFS in a systemic inflammation state. Available at. https://www.intbrazjurol.com.br/pdf/aop/2019-0228OA.pdf.

摘要

目的

探讨全身性炎症状态下肥胖(通过 BMI 衡量)对肾细胞癌的预后价值。

患者与方法

回顾性收集了 2005 年至 2010 年间 540 例接受手术治疗的中国局限性肾细胞癌患者的临床病理和血液学数据。通过接收者操作特征(ROC)曲线确定了用于癌症特异性生存(CSS)的中性粒细胞-淋巴细胞比值(NLR,全身性炎症状态的指标)和 BMI 的最佳截断值分别为 2.12 和 23.32。使用 Kaplan-Meier 方法绘制生存曲线。使用单变量和多变量 Cox 回归分析评估 BMI 在不同 NLR 的局限性 RCC 患者中的预后价值。

结果

总体而言,36 例患者死亡,中位随访时间为 70 个月。中位总生存期(OS)为 66 个月,5 年 OS 率为 92.7%。在所有患者的多变量分析中,较高的 BMI 是所有患者 CSS 的独立保护因素(p=0.048)。然而,在全身性炎症亚组(高 NLR 亚组)患者中,较高的 BMI(肥胖)被证明是 CSS(p=0.025)和 RFS(p=0.048)的独立保护因素。

结论

在局限性 RCC 患者中,肥胖是全身性炎症状态下 CSS 和 RFS 的独立保护因素。可在. https://www.intbrazjurol.com.br/pdf/aop/2019-0228OA.pdf 查看全文。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/ab510186c130/1677-6119-ibju-46-04-0585-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/71f153c1a9b6/1677-6119-ibju-46-04-0585-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/d0f9445c8f99/1677-6119-ibju-46-04-0585-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/10b91ffa6ec4/1677-6119-ibju-46-04-0585-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/b242f51ac2d0/1677-6119-ibju-46-04-0585-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/3c91c47d94d6/1677-6119-ibju-46-04-0585-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/55b62fa6d73e/1677-6119-ibju-46-04-0585-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/5bcc7a442741/1677-6119-ibju-46-04-0585-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/ab510186c130/1677-6119-ibju-46-04-0585-gf08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/71f153c1a9b6/1677-6119-ibju-46-04-0585-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/d0f9445c8f99/1677-6119-ibju-46-04-0585-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/10b91ffa6ec4/1677-6119-ibju-46-04-0585-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/b242f51ac2d0/1677-6119-ibju-46-04-0585-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/3c91c47d94d6/1677-6119-ibju-46-04-0585-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/55b62fa6d73e/1677-6119-ibju-46-04-0585-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/5bcc7a442741/1677-6119-ibju-46-04-0585-gf07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e0/7239303/ab510186c130/1677-6119-ibju-46-04-0585-gf08.jpg

相似文献

1
Obesity: An independent protective factor for localized renal cell carcinoma in a systemic inflammation state.肥胖:全身性炎症状态下局部肾细胞癌的独立保护因素。
Int Braz J Urol. 2020 Jul-Aug;46(4):585-598. doi: 10.1590/S1677-5538.IBJU.2019.0228. Epub 2020 Mar 15.
2
The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及血红蛋白与血小板比值对局限性肾细胞癌肿瘤学结局的影响。
Prog Urol. 2019 Jul-Aug;29(8-9):423-431. doi: 10.1016/j.purol.2019.05.008. Epub 2019 Jun 10.
3
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.术前中性粒细胞与淋巴细胞比值(NLR)、动态中性粒细胞与淋巴细胞比值(dNLR)、血小板与淋巴细胞比值(PLR)及C反应蛋白(CRP)在肾细胞癌手术患者中的预后价值
World J Urol. 2017 Feb;35(2):261-270. doi: 10.1007/s00345-016-1864-9. Epub 2016 Jun 2.
4
Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.高血压对肾细胞癌预后术前中性粒细胞与淋巴细胞比值评估的影响。
Urol Oncol. 2016 May;34(5):239.e9-15. doi: 10.1016/j.urolonc.2015.12.006. Epub 2016 Jan 21.
5
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.在考虑C反应蛋白水平的情况下,对透明细胞肾细胞癌中预处理得出的中性粒细胞与淋巴细胞比值的潜在预后价值进行批判性评估。
Br J Cancer. 2017 Jan 3;116(1):85-90. doi: 10.1038/bjc.2016.393. Epub 2016 Dec 1.
6
Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.极端肥胖并不能预测肾细胞癌手术后的不良癌症预后。
BJU Int. 2016 Sep;118(3):399-407. doi: 10.1111/bju.13381. Epub 2015 Dec 22.
7
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
8
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
9
Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.术前系统性炎症评分(SIS)优于中性粒细胞与淋巴细胞比值(NLR),是食管鳞癌患者的预测指标。
BMC Cancer. 2019 Jul 22;19(1):721. doi: 10.1186/s12885-019-5940-6.
10
Preoperative Neutrophil-lymphocyte Ratio as a Predictor of Overall Survival in Patients with Localized Renal Cell Carcinoma.术前中性粒细胞与淋巴细胞比值作为局限性肾细胞癌患者总生存的预测指标
Urol J. 2020 Jan 26;17(1):30-35. doi: 10.22037/uj.v0i0.4541.

引用本文的文献

1
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.副肿瘤消退对转移性肾细胞癌患者具有预后价值。
Cancers (Basel). 2024 Oct 30;16(21):3678. doi: 10.3390/cancers16213678.
2
Renal Cell Carcinoma Associated With HIV/AIDS: A Review of the Epidemiology, Risk Factors, Diagnosis, and Treatment.与人类免疫缺陷病毒/获得性免疫综合征相关的肾细胞癌:流行病学、危险因素、诊断及治疗综述
Front Oncol. 2022 Apr 1;12:872438. doi: 10.3389/fonc.2022.872438. eCollection 2022.
3
In these difficult times of COVID-19, urologic research cannot stop: COVID-19 pandemic and reconstructive urology highlighted in International Brazilian Journal of Urology.

本文引用的文献

1
Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.肾细胞癌生存率与体重指数:一项剂量反应荟萃分析揭示了悖论中的另一个潜在悖论。
Int J Obes (Lond). 2016 Dec;40(12):1817-1822. doi: 10.1038/ijo.2016.171. Epub 2016 Sep 30.
2
Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma.局部高危肾细胞癌前瞻性随机试验中的体重指数与生存率
Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1326-32. doi: 10.1158/1055-9965.EPI-16-0226. Epub 2016 Jul 14.
3
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
在新冠疫情的艰难时期,泌尿学研究不能停止:《巴西国际泌尿学杂志》重点关注新冠疫情与重建性泌尿学。
Int Braz J Urol. 2020 Jul-Aug;46(4):496-498. doi: 10.1590/S1677-5538.IBJU.2020.04.01.
术前中性粒细胞与淋巴细胞比值(NLR)、动态中性粒细胞与淋巴细胞比值(dNLR)、血小板与淋巴细胞比值(PLR)及C反应蛋白(CRP)在肾细胞癌手术患者中的预后价值
World J Urol. 2017 Feb;35(2):261-270. doi: 10.1007/s00345-016-1864-9. Epub 2016 Jun 2.
4
Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients.新诊断2型糖尿病患者中性粒细胞与淋巴细胞比值和胰岛素抵抗的关系
BMC Endocr Disord. 2015 Mar 2;15:9. doi: 10.1186/s12902-015-0002-9.
5
Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.中性粒细胞与淋巴细胞比值在肾细胞癌中的预后作用:一项荟萃分析。
BMJ Open. 2015 Apr 8;5(4):e006404. doi: 10.1136/bmjopen-2014-006404.
6
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.系统性炎症标志物可预测晚期肾细胞癌患者的生存。
Br J Cancer. 2013 Jul 9;109(1):147-53. doi: 10.1038/bjc.2013.300. Epub 2013 Jun 18.
7
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.术前中性粒细胞与淋巴细胞比值是肝癌肝切除术后生存的预测因素:一项回顾性分析。
Ann Surg. 2013 Aug;258(2):301-5. doi: 10.1097/SLA.0b013e318297ad6b.
8
Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.验证治疗前中性粒细胞与淋巴细胞比值作为大型欧洲肾细胞癌患者队列的预后因素。
Br J Cancer. 2013 Mar 5;108(4):901-7. doi: 10.1038/bjc.2013.28. Epub 2013 Feb 5.
9
Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.体重指数与肾细胞癌患者的生存:基于临床的队列研究和荟萃分析。
Int J Cancer. 2013 Feb 1;132(3):625-34. doi: 10.1002/ijc.27639. Epub 2012 Jun 20.
10
The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.肾细胞癌大小与其组织病理学特征的相关性:1867 例肾细胞癌的单中心研究。
BJU Int. 2012 Dec;110(11 Pt B):E481-5. doi: 10.1111/j.1464-410X.2012.11173.x. Epub 2012 Apr 30.